SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. ) TITAN PHARMACEUTICALS INC ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 888314101 ----------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement []. - ---------- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 888314101 13G Page 2 of 8 Pages - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) Morgan Stanley IRS # 39-314-5972 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION The state of organization is Delaware. - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 1,884,600 REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 0 -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,884,600 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,884,600 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.8179% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IA, CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 888314101 13G Page 3 of 8 Pages - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) Morgan Stanley Capital Services Inc IRS# 13-3292567 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION The state of organization is Delaware. - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 1,884,600 REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER WITH 0 -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,884,600 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,884,600 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.8179% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IA, CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 888314101 13G Page 4 of 8 Pages Item 1. (a) Name of Issuer: TITAN PHARMACEUTICALS INC -------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices: 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO, CA 94080 -------------------------------------------------------------- Item 2. (a) Name of Person Filing: (a) Morgan Stanley (b) Morgan Stanley Capital Services Inc -------------------------------------------------------------- (b) Address of Principal Business Office, or if None, Residence: (a) 1585 Broadway New York, New York 10036 (b) 1585 Broadway New York, New York 10036 -------------------------------------------------------------- (c) Citizenship: Incorporated by reference to Item 4 of the cover page pertaining to each reporting person. -------------------------------------------------------------- (d) Title of Class of Securities: Common Stock -------------------------------------------------------------- (e) CUSIP Number: 888314101 -------------------------------------------------------------- Item 3. (a) Morgan Stanley is a parent holding company. CUSIP No. 888314101 13-G Page 5 of 8 Pages Item 4. Ownership. Incorporated by reference to Items (5) - (9) and (11) of the cover page. (a) Morgan Stanley is filing solely in its capacity as the parent company of, and indirect beneficial owner of securities held by, one of its business units. Item 5. Ownership of Five Percent or Less of a Class. Inapplicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Accounts managed on a discretionary basis by Morgan Stanley Capital Services Inc, a wholly owned subsidiary of Morgan Stanley, are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from, the sale of such securities. No such account holds more than 5 percent of the class. See item 4 (a) Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. Item 8. Identification and Classification of Members of the Group. Item 9. Notice of Dissolution of Group. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. CUSIP No. 888314101 13-G Page 6 of 8 Pages Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 18, 2003 Signature: /s/ Dennine Bullard ----------------------------------------------------------------- Name/Title Dennine Bullard /Vice President, Morgan Stanley & Co. Incorporated ----------------------------------------------------------------- MORGAN STANLEY Date: February 18, 2003 Signature: /s/ Jonathan Barton ----------------------------------------------------------------- Name/Title Jonathan Barton /Managing Director, Morgan Stanley Capital Services Inc. ----------------------------------------------------------------- MORGAN STANLEY CAPITAL SERVICES INC INDEX TO EXHIBITS PAGE ----------------- ---- EXHIBIT 1 Agreement to Make a Joint Filing 7 EXHIBIT 2 Secretary's Certificate Authorizing Dennine Bullard 8 to Sign on behalf of Morgan Stanley * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EX-99 JOINT FILING AGREEMENT CUSIP No. 888314101 13-G Page 7 of 8 Pages EXHIBIT 1 TO SCHEDULE 13G --------------------------------------------------- FEBRUARY 18, 2003 --------------------------------------------------- MORGAN STANLEY and MORGAN STANLEY CAPITAL SERVICES INC, hereby agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties. MORGAN STANLEY BY: /s/ Dennine Bullard -------------------------------------------------------------------- Dennine Bullard/ Vice President Morgan Stanley & Co. Incorporated MORGAN STANLEY CAPITAL SERVICES INC BY: /s/ Jonathan Barton -------------------------------------------------------------------- Jonathan Barton /Managing Director, Morgan Stanley Capital Services Inc. EX-99.1 SECRETARY'S CERTIFICATE CUSIP No. 888314101 Page 8 of 8 Pages EXHIBIT 2 MORGAN STANLEY SECRETARY'S CERTIFICATE I, Charlene R. Herzer, a duly elected and Assistant Secretary of Morgan Stanley, a corporation organized and existing under the laws of the State of Delaware (the "Corporation"), certify as follows: (1) Donald G. Kempf, Jr. is the duly elected Executive Vice President, Chief Legal Officer and Secretary of the Corporation; (2) Pursuant to Section 7.01 of the Bylaws of the Corporation and resolutions approved by the Board of Directors of the Corporation on September 25,1998, the Chief Legal Officer is authorized to enter into agreements and other instruments on behalf of the Corporation and may delegate such powers to others under his jurisdiction; and (3) Donald G. Kempf signed a Delegation of Authority as of February 23, 2000, which authorized Dennine Bullard to sign reports to be filed under Section 13 and 16 of the Securities Exchange Act of 1934 on behalf of the Corporation. Such authorization is in full force and efect as of this date. IN WITNESS WHEREOF, I have hereunto set my name and affixed the seal of the Corporation as of the 5th day of February, 2003. ______________________________ Charlene R. Herzer Assistant Secretary